Method for detecting NOD1 gene single nucleotide polymorphism with HRM (High Resolution Melting) technology

A single nucleotide polymorphism and technology detection technology, applied in the field of HRM technology detection of NOD1 gene single nucleotide polymorphism, can solve the problems of high reaction conditions, complicated operation process, cumbersome test process, etc., and achieve high sensitivity And the effect of high specificity, good repeatability, and shortened detection time

Inactive Publication Date: 2018-07-31
济南艾迪康医学检验中心有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

RFLP does not require high equipment, but the operation process is complicated, and false negative errors are prone to occur; AS-PCR has high requirements on primer design

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting NOD1 gene single nucleotide polymorphism with HRM (High Resolution Melting) technology
  • Method for detecting NOD1 gene single nucleotide polymorphism with HRM (High Resolution Melting) technology
  • Method for detecting NOD1 gene single nucleotide polymorphism with HRM (High Resolution Melting) technology

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0023] Example 1

[0024] The high-resolution melting curve (HRM) method is used to detect the SNP site rs2075820 of the NOD1 gene in the subject, including obtaining sample DNA and providing reagents required for sequencing. Refer to Example 2 for specific operation steps. The reagents include: whole blood genomic DNA extraction kit (QIAGEN), HRM detection kit FP210 (Tiangen Biochemical Technology Co., Ltd., Beijing, China), primers for detecting rs2075820 site, standard substances and negative control substances. The primers for detecting rs2075820 site are:

[0025] NOD1-F-HRM:GCTTCAAGGAAAGTGACAGGC;

[0026] NOD1-R-HRM: CAGGTCCAAGTCCGAGTGC.

[0027] Standards are GG genotype, GA genotype and AA genotype DNA specimens; negative control: solution without DNA.

[0028] The PCR reaction solution of the detection system includes:

[0029]

[0030] The PCR reaction program is:

[0031]

[0032] The present invention also uses a sequencing method to further verify the result of the HRM meth...

Example Embodiment

[0041] Example 2

[0042] The operation process of the blood / cell / tissue genomic DNA extraction kit (QIAGEN):

[0043] (1) Extraction of genomic DNA from whole blood

[0044] 1) Add 20μl QIAGEN Protease (or proteinase K) to the bottom of a 1.5ml centrifuge tube. .

[0045] 2) Add 200μl of plasma to the centrifuge tube.

[0046] 3) Add 200μl Buffer AL and shake for 15s. (Note: Do not add QIAGEN Protease or proteinaseK directly to Buffer AL. If the sample size is large, QIAGEN Protease and Buffer AL will increase proportionally.)

[0047] 4) Water bath at 56°C for 10 minutes, and then centrifuge briefly to remove the liquid on the inner edge of the centrifuge tube cap.

[0048] 5) Add 200μl of ethanol (96%-100%), shake for 15s, and centrifuge briefly to remove the liquid on the inner edge of the centrifuge tube cap.

[0049] 6) Carefully add the above-obtained mixture (including the precipitate) to the QIAamp Mini spin column (without wetting the rim), put the spin column into a 2ml collec...

Example Embodiment

[0096] Example 3 Detection of clinical samples

[0097] Take 40 clinical samples to be tested, extract the genome, prepare the reagents and test according to the methods and reagents described in Examples 1 and 2.

[0098] Add 1 μL of each sample to the PCR reaction solution of the detection system. Make a standard product at the same time. Detect with a fluorescent PCR machine for 120 minutes.

[0099] Such as figure 1 Shown are the HRM results of standard AA, standard GA and standard GG.

[0100] Such as figure 2 Shown are the HRM results of 40 clinical samples and standards.

[0101] According to the HRM results, the genotypes of the NOD1 gene rs2075820 locus of 40 screening samples were determined as shown in Table 1.

[0102] Table 1

[0103]

[0104]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to detection of a NOD1 gene single nucleotide polymorphism site rs2075820 in a patient suffering from a H.pylori infection-correlated disease, in particular to an amplification primer for detecting NOD1 gene single nucleotide polymorphism with a HRM detection technology and a detection method. The method has the advantages of easiness and convenience in operation, high detection speed, high flux, low cost, high sensitivity, high specificity, high repeatability and convenience in interpretation of results. The method facilitates the early detection, early diagnosis and early treatment of clinical H.pylori infection-correlated diseases, and has important significance to the immediate intervention and treatment for avoiding disease progression, adjustment of treatment scheme, prognostic prediction and prevention of clinical relapse.

Description

technical field [0001] This patent relates to a gene polymorphism detection method for clinical testing, which uses HRM technology to detect the SNP site rs2075820 of the NOD1 gene in patients with Hp infection, and at the same time conducts a more accurate screening of high-risk groups. The method can effectively save detection time and cost and improve detection accuracy. technical background [0002] Gastric cancer is one of the most common malignant tumors in the world, accounting for the fourth place in the incidence of various malignant tumors and the second place in the cause of death of malignant tumors after lung cancer. The World Health Organization (WHO) reported that there were 1.1 million new gastric cancer patients in the world in 2010, 60% of which occurred in developing countries. China is a country with a high incidence of gastric cancer, and the incidence and mortality of gastric cancer rank third among malignant tumors. Studies have found that the occurr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/6858C12N15/11
CPCC12Q1/6858C12Q2531/113C12Q2527/107C12Q2545/113
Inventor 牛林梅林筱剑王淑一
Owner 济南艾迪康医学检验中心有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap